Key result
In young adults under 30 years with acute coronary syndrome, the 5-year major adverse cardiac event rate was 19% overall, with no significant difference between those with atypical etiologies and those with atherosclerosis.
Cohort (n=27)
Yes
Answers are grounded in this paper and cite their sources.
ACS in patients under 30 is rare (0.05% of angiograms) and has diverse etiologies, but shows satisfactory 5-year clinical outcomes with a 19% MACE rate.
BACKGROUND: Coronary atherosclerosis begins early in life, but acute coronary syndromes in adults aged <30 years are exceptional. We aimed to investigate the rate of occurrence, clinical and angiographic characteristics, and long-term clinical outcome of acute coronary syndrome (ACS) in young patients who were referred to two Swiss hospitals. METHODS: From 1994 to 2010, data on all patients with ACS aged <30 years were retrospectively retrieved from our database and the patients were contacted by phone or physician's visit. Baseline, lesion and procedural characteristics, and clinical outcome were compared between patients in whom an underlying atypical aetiology was found (non-ATS group; ATS: atherosclerosis) and patients in whom no such aetiology was detected (ATS group). The clinical endpoint was freedom from any major adverse cardiac event (MACE) during follow-up. RESULTS: A total of 27 young patients with ACS aged <30 years were admitted during the study period. They accounted for 0.05% of all coronary angiograms performed. Mean patient age was 26.8 ± 3.5 years and 22 patients (81%) were men. Current smoking (81%) and dyslipidaemia (59%) were the most frequent risk factors. Typical chest pain (n = 23; 85%) and ST-segment elevation myocardial infarction (STEMI; n = 18 [67%]) were most often found. The ATS group consisted of 17 patients (63%) and the non-ATS group of 10 patients (37%). Hereditary thrombophilia was the most frequently encountered atypical aetiology (n = 4; 15%). At 5 years, mortality and MACE rate were 7% and 19%, respectively. CONCLUSION: ACS in young patients is an uncommon condition with a variety of possible aetiologies and distinct risk factors. In-hospital and 5-year clinical outcome is satisfactory.
No takes yet. Share an insight, caveat, or question.
Puricel et al. (2013) conducted a cohort in Acute coronary syndrome (n=27). Atypical etiology (non-atherosclerosis) vs. Atherosclerosis was evaluated on Major adverse cardiac event (MACE) at 5 years (p=0.62). In young adults under 30 years with acute coronary syndrome, the 5-year major adverse cardiac event rate was 19% overall, with no significant difference between those with atypical etiologies and those with atherosclerosis.
Synapse has enriched 10 related papers. Consider them for comparative context: